Yeah they have definitely chopped what you can deal on. I don't care for the margins on the smallies but reckon they should still allow them to be traded without any margin. At least then they would keep you on their platform all the time.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
